Europe Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Country and Growth Forecast, 2023

List of Tables

The Europe Antibody Therapeutics Market would witness market growth of 14.0 % CAGR during the forecast period (2023-2030).

Antibody therapeutics have successfully treated autoimmune diseases by modulating the immune system's activity. In conditions such as rheumatoid arthritis, psoriasis, and lupus, monoclonal antibodies can target inflammatory cytokines or immune cells involved in the disease process. By dampening immune responses, these antibodies help alleviate symptoms and reduce the progression of autoimmune disorders. Antibody therapeutics have applications in hematological disorders, including thrombocytopenia and hemophilia. Monoclonal antibodies can target specific components involved in blood clotting or platelet production, providing therapeutic options for patients with bleeding disorders. Antibody therapeutics are under exploration for the treatment of neurological disorders, including Alzheimer's disease and multiple sclerosis. Monoclonal antibodies may target pathological proteins involved in neurodegenerative processes or modulate immune responses within the central nervous system to mitigate the progression of these disorders. In transplantation medicine, antibody therapeutics are used to prevent organ rejection.

The use of antibody therapies for respiratory conditions, including asthma and chronic obstructive pulmonary disease (COPD), is being explored. Monoclonal antibodies can target specific inflammatory pathways involved in these conditions, providing a targeted and personalized approach to managing respiratory diseases. Inflammatory bowel diseases, like Crohn's disease and ulcerative colitis, are among the gastrointestinal disorders where antibody therapeutics have demonstrated efficacy. Monoclonal antibodies can modulate immune responses in the gut, reducing inflammation and improving symptoms in patients with these chronic conditions. Antibody therapeutics treat dermatological conditions, including psoriasis and atopic dermatitis. Monoclonal antibodies targeting specific cytokines involved in skin inflammation help manage these disorders and improve patients' quality of life.

As per Destatis, 2020, since younger birth cohorts also show decreasing numbers of people, over 65-year-olds make up an ever-larger proportion of the total population over time. The very old group, above 85, is particularly fast growing. Their number increased from 1.2 million in 1991 to 2.4 million in 2019. Similarly, according to a report on the French aging policy published by the United Nations, as in other European countries, France faces a continuous and significant increase in older people: in 2012, there were 15 million people aged more than 60 years old in France. This number will reach 24 million in 2060. The factors mentioned above will drive the regional market growth.

The Germany market dominated the Europe Antibody Therapeutics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $41,487.8 million by 2030. The UK market is registering a CAGR of 13.1% during (2023 - 2030). Additionally, The France market would showcase a CAGR of 14.9% during (2023 - 2030).

Based on Route of Administration, the market is segmented into Intravenous, Subcutaneous, and Others. Based on Format, the market is segmented into, Monoclonal Antibody, Polyclonal Antibody Therapy, Bispecific Antibody, Antibody fragment & Others. Based on Source, the market is segmented into Human, Humanized, and Chimeric. Based on End User, the market is segmented into Hospitals, Long-term care facilities, and Others. Based on Disease Areas, the market is segmented into Autoimmune & Inflammatory Diseases, Neurology, Osteology, Hematology, Oncology, Infectious Diseases, Immunology, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd, AbbVie, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Merck KGaA, Bristol Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., Novartis AG, Biogen, Inc. and Amgen, Inc.

Scope of the Study

Market Segments covered in the Report:

By Route of Administration

Intravenous
Subcutaneous
Others

By Format

Monoclonal Antibody
Polyclonal Antibody Therapy
Bispecific Antibody
Antibody fragment & Others

By Source

Human
Humanized
Chimeric

By End User

Hospitals
Long-term care facilities
Other

By Disease Areas

Autoimmune & Inflammatory Diseases
Neurology
Osteology
Hematology
Oncology
Infectious Diseases
Immunology
Others

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Companies Profiled

F. Hoffmann-La Roche Ltd
AbbVie, Inc.
Johnson & Johnson (Johnson & Johnson Services, Inc.)
Merck KGaA
Bristol Myers Squibb Company
AstraZeneca PLC
Sanofi S.A.
Novartis AG
Biogen, Inc.
Amgen, Inc.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe Antibody Therapeutics Market, by Route of Administration
- 1.4.2 Europe Antibody Therapeutics Market, by Format
- 1.4.3 Europe Antibody Therapeutics Market, by Source
- 1.4.4 Europe Antibody Therapeutics Market, by End User
- 1.4.5 Europe Antibody Therapeutics Market, by Disease Areas
- 1.4.6 Europe Antibody Therapeutics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Antibody Therapeutics market.

Chapter 5. Europe Antibody Therapeutics Market by Route of Administration

5.1 Europe Intravenous Market by Country
5.2 Europe Subcutaneous Market by Country
5.3 Europe Others Market by Country

Chapter 6. Europe Antibody Therapeutics Market by Format

6.1 Europe Monoclonal Antibody Market by Country
6.2 Europe Polyclonal Antibody Therapy Market by Country
6.3 Europe Bispecific Antibody Market by Country
6.4 Europe Antibody fragment & Others Market by Country

Chapter 7. Europe Antibody Therapeutics Market by Source

7.1 Europe Human Market by Country
7.2 Europe Humanized Market by Country
7.3 Europe Chimeric Market by Country
7.4 Europe Others Market by Country

Chapter 8. Europe Antibody Therapeutics Market by End User

8.1 Europe Hospitals Market by Country
8.2 Europe Long-term care facilities Market by Country
8.3 Europe Others Market by Country

Chapter 9. Europe Antibody Therapeutics Market by Disease Areas

9.1 Europe Autoimmune & Inflammatory Diseases Market by Country
9.2 Europe Neurology Market by Country
9.3 Europe Osteology Market by Country
9.4 Europe Hematology Market by Country
9.5 Europe Oncology Market by Country
9.6 Europe Infectious Diseases Market by Country
9.7 Europe Immunology Market by Country
9.8 Europe Others Market by Country

Chapter 10. Europe Antibody Therapeutics Market by Country

10.1 Germany Antibody Therapeutics Market
- 10.1.1 Germany Antibody Therapeutics Market by Route of Administration
- 10.1.2 Germany Antibody Therapeutics Market by Format
- 10.1.3 Germany Antibody Therapeutics Market by Source
- 10.1.4 Germany Antibody Therapeutics Market by End User
- 10.1.5 Germany Antibody Therapeutics Market by Disease Areas
10.2 UK Antibody Therapeutics Market
- 10.2.1 UK Antibody Therapeutics Market by Route of Administration
- 10.2.2 UK Antibody Therapeutics Market by Format
- 10.2.3 UK Antibody Therapeutics Market by Source
- 10.2.4 UK Antibody Therapeutics Market by End User
- 10.2.5 UK Antibody Therapeutics Market by Disease Areas
10.3 France Antibody Therapeutics Market
- 10.3.1 France Antibody Therapeutics Market by Route of Administration
- 10.3.2 France Antibody Therapeutics Market by Format
- 10.3.3 France Antibody Therapeutics Market by Source
- 10.3.4 France Antibody Therapeutics Market by End User
- 10.3.5 France Antibody Therapeutics Market by Disease Areas
10.4 Russia Antibody Therapeutics Market
- 10.4.1 Russia Antibody Therapeutics Market by Route of Administration
- 10.4.2 Russia Antibody Therapeutics Market by Format
- 10.4.3 Russia Antibody Therapeutics Market by Source
- 10.4.4 Russia Antibody Therapeutics Market by End User
- 10.4.5 Russia Antibody Therapeutics Market by Disease Areas
10.5 Spain Antibody Therapeutics Market
- 10.5.1 Spain Antibody Therapeutics Market by Route of Administration
- 10.5.2 Spain Antibody Therapeutics Market by Format
- 10.5.3 Spain Antibody Therapeutics Market by Source
- 10.5.4 Spain Antibody Therapeutics Market by End User
- 10.5.5 Spain Antibody Therapeutics Market by Disease Areas
10.6 Italy Antibody Therapeutics Market
- 10.6.1 Italy Antibody Therapeutics Market by Route of Administration
- 10.6.2 Italy Antibody Therapeutics Market by Format
- 10.6.3 Italy Antibody Therapeutics Market by Source
- 10.6.4 Italy Antibody Therapeutics Market by End User
- 10.6.5 Italy Antibody Therapeutics Market by Disease Areas
10.7 Rest of Europe Antibody Therapeutics Market
- 10.7.1 Rest of Europe Antibody Therapeutics Market by Route of Administration
- 10.7.2 Rest of Europe Antibody Therapeutics Market by Format
- 10.7.3 Rest of Europe Antibody Therapeutics Market by Source
- 10.7.4 Rest of Europe Antibody Therapeutics Market by End User
- 10.7.5 Rest of Europe Antibody Therapeutics Market by Disease Areas

Chapter 11. Company Profiles

11.1 F. Hoffmann-La Roche Ltd.
- 11.1.1 Company Overview
- 11.1.2 Financial Analysis
- 11.1.3 Segmental and Regional Analysis
- 11.1.4 Research & Development Expense
- 11.1.5 Recent strategies and developments:
  - 11.1.5.1 Partnerships, Collaborations, and Agreements:
  - 11.1.5.2 Product Launches and Product Expansions:
- 11.1.6 SWOT Analysis
11.2 AbbVie, Inc.
- 11.2.1 Company Overview
- 11.2.2 Financial Analysis
- 11.2.3 Regional Analysis
- 11.2.4 Research & Development Expense
- 11.2.5 Recent strategies and developments:
  - 11.2.5.1 Partnerships, Collaborations, and Agreements:
  - 11.2.5.2 Acquisition and Mergers:
- 11.2.6 SWOT Analysis
11.3 Johnson & Johnson (Johnson & Johnson Services, Inc.)
- 11.3.1 Company Overview
- 11.3.2 Financial Analysis
- 11.3.3 Segmental &Regional Analysis
- 11.3.4 Research & Development Expenses
- 11.3.5 Recent strategies and developments:
  - 11.3.5.1 Partnerships, Collaborations, and Agreements:
- 11.3.6 SWOT Analysis
11.4 Merck KGaA
- 11.4.1 Company Overview
- 11.4.2 Financial Analysis
- 11.4.3 Segmental and Regional Analysis
- 11.4.4 Research & Development Expense
- 11.4.5 Recent strategies and developments:
  - 11.4.5.1 Partnerships, Collaborations, and Agreements:
- 11.4.6 SWOT Analysis
11.5 Bristol Myers Squibb Company
- 11.5.1 Company Overview
- 11.5.2 Financial Analysis
- 11.5.3 Regional Analysis
- 11.5.4 Research & Development Expenses
- 11.5.5 Recent strategies and developments:
  - 11.5.5.1 Acquisition and Mergers:
- 11.5.6 SWOT Analysis
11.6 AstraZeneca PLC
- 11.6.1 Company Overview
- 11.6.2 Financial Analysis
- 11.6.3 Regional Analysis
- 11.6.4 Research & Development Expenses
- 11.6.5 SWOT Analysis
11.7 Sanofi S.A.
- 11.7.1 Company Overview
- 11.7.2 Financial Analysis
- 11.7.3 Segmental and Regional Analysis
- 11.7.4 Research & Development Expense
- 11.7.5 SWOT Analysis
11.8 Novartis AG
- 11.8.1 Company Overview
- 11.8.2 Financial Analysis
- 11.8.3 Segmental and Regional Analysis
- 11.8.4 Research & Development Expense
- 11.8.5 SWOT Analysis
11.9 Biogen, Inc.
- 11.9.1 Company Overview
- 11.9.2 Financial Analysis
- 11.9.3 Regional Analysis
- 11.9.4 Research & Development Expense
- 11.9.5 SWOT Analysis
11.10. Amgen, Inc.
- 11.10.1 Company Overview
- 11.10.2 Financial Analysis
- 11.10.3 Regional Analysis
- 11.10.4 Research & Development Expenses
- 11.10.5 SWOT Analysis

LIST OF TABLES

TABLE 1 Europe Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 2 Europe Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 3 Europe Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 4 Europe Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 5 Europe Intravenous Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Intravenous Market by Country, 2023 - 2030, USD Million
TABLE 7 Europe Subcutaneous Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Subcutaneous Market by Country, 2023 - 2030, USD Million
TABLE 9 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 12 Europe Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 13 Europe Monoclonal Antibody Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe Monoclonal Antibody Market by Country, 2023 - 2030, USD Million
TABLE 15 Europe Polyclonal Antibody Therapy Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Polyclonal Antibody Therapy Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe Bispecific Antibody Market by Country, 2019 - 2022, USD Million
TABLE 18 Europe Bispecific Antibody Market by Country, 2023 - 2030, USD Million
TABLE 19 Europe Antibody fragment & Others Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Antibody fragment & Others Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 22 Europe Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 23 Europe Human Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Human Market by Country, 2023 - 2030, USD Million
TABLE 25 Europe Humanized Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Humanized Market by Country, 2023 - 2030, USD Million
TABLE 27 Europe Chimeric Market by Country, 2019 - 2022, USD Million
TABLE 28 Europe Chimeric Market by Country, 2023 - 2030, USD Million
TABLE 29 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 30 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 31 Europe Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 32 Europe Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 33 Europe Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 34 Europe Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 35 Europe Long-term care facilities Market by Country, 2019 - 2022, USD Million
TABLE 36 Europe Long-term care facilities Market by Country, 2023 - 2030, USD Million
TABLE 37 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 38 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 39 Europe Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 40 Europe Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 41 Europe Autoimmune & Inflammatory Diseases Market by Country, 2019 - 2022, USD Million
TABLE 42 Europe Autoimmune & Inflammatory Diseases Market by Country, 2023 - 2030, USD Million
TABLE 43 Europe Neurology Market by Country, 2019 - 2022, USD Million
TABLE 44 Europe Neurology Market by Country, 2023 - 2030, USD Million
TABLE 45 Europe Osteology Market by Country, 2019 - 2022, USD Million
TABLE 46 Europe Osteology Market by Country, 2023 - 2030, USD Million
TABLE 47 Europe Hematology Market by Country, 2019 - 2022, USD Million
TABLE 48 Europe Hematology Market by Country, 2023 - 2030, USD Million
TABLE 49 Europe Oncology Market by Country, 2019 - 2022, USD Million
TABLE 50 Europe Oncology Market by Country, 2023 - 2030, USD Million
TABLE 51 Europe Infectious Diseases Market by Country, 2019 - 2022, USD Million
TABLE 52 Europe Infectious Diseases Market by Country, 2023 - 2030, USD Million
TABLE 53 Europe Immunology Market by Country, 2019 - 2022, USD Million
TABLE 54 Europe Immunology Market by Country, 2023 - 2030, USD Million
TABLE 55 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 56 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 57 Europe Antibody Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 58 Europe Antibody Therapeutics Market by Country, 2023 - 2030, USD Million
TABLE 59 Germany Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 60 Germany Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 61 Germany Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 62 Germany Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 63 Germany Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 64 Germany Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 65 Germany Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 66 Germany Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 67 Germany Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 68 Germany Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 69 Germany Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 70 Germany Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 71 UK Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 72 UK Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 73 UK Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 74 UK Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 75 UK Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 76 UK Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 77 UK Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 78 UK Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 79 UK Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 80 UK Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 81 UK Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 82 UK Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 83 France Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 84 France Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 85 France Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 86 France Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 87 France Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 88 France Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 89 France Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 90 France Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 91 France Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 92 France Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 93 France Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 94 France Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 95 Russia Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 96 Russia Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 97 Russia Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 98 Russia Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 99 Russia Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 100 Russia Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 101 Russia Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 102 Russia Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 103 Russia Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 104 Russia Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 105 Russia Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 106 Russia Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 107 Spain Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 108 Spain Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 109 Spain Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 110 Spain Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 111 Spain Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 112 Spain Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 113 Spain Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 114 Spain Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 115 Spain Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 116 Spain Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 117 Spain Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 118 Spain Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 119 Italy Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 120 Italy Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 121 Italy Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 122 Italy Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 123 Italy Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 124 Italy Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 125 Italy Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 126 Italy Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 127 Italy Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 128 Italy Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 129 Italy Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 130 Italy Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 131 Rest of Europe Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 132 Rest of Europe Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 133 Rest of Europe Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 134 Rest of Europe Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 135 Rest of Europe Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 136 Rest of Europe Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 137 Rest of Europe Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 138 Rest of Europe Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 139 Rest of Europe Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 140 Rest of Europe Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 141 Rest of Europe Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 142 Rest of Europe Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 143 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 144 Key information - AbbVie, Inc.
TABLE 145 Key Information - Johnson & Johnson
TABLE 146 key Information - Merck KGaA
TABLE 147 Key Information - Bristol Myers Squibb Company
TABLE 148 KEY INFORMATION - AstraZeneca PLC
TABLE 149 Key Information - Sanofi S.A.
TABLE 150 Key Information - Novartis AG
TABLE 151 Key Information - Biogen, Inc.
TABLE 152 Key Information - Amgen, Inc.

Europe Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents